Toll-like receptor 8

Toll-like receptor 8 (TLR8) is a protein that in humans is encoded by the TLR8 gene. It is a member of the Toll-like receptor (TLR) family, which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. TLR8 specifically has been shown to recognize single-stranded RNA (ssRNA) from viruses, leading to the activation of the nuclear factor kappa B (NF-κB) signaling pathway.

Structure and Function

TLR8 is composed of extracellular leucine-rich repeat (LRR) motifs and a cytoplasmic Toll/IL-1 receptor (TIR) domain. The LRR motifs are involved in the recognition of microbial components, while the TIR domain transduces the signal into the cell, leading to NF-κB activation. This activation results in the production of pro-inflammatory cytokines, which are crucial for the immune response to infection.

Unlike other TLRs that are expressed on the cell surface, TLR8 is primarily found in intracellular compartments, such as endosomes. This localization allows TLR8 to recognize ssRNA from viruses that have been internalized by the cell. Upon recognition of ssRNA, TLR8 undergoes a conformational change that leads to the recruitment of adaptor proteins, such as MyD88, and the subsequent activation of downstream signaling pathways.

Clinical Significance

TLR8 plays a significant role in the immune response to viral infections. It has been implicated in the recognition of various RNA viruses, including influenza virus, HIV, and hepatitis C virus. Activation of TLR8 can lead to the production of type I interferons and other cytokines, which are important for controlling viral replication and spread.

Furthermore, TLR8 is involved in the pathogenesis of several autoimmune and inflammatory diseases. Aberrant activation of TLR8 can lead to excessive inflammation and tissue damage. Therefore, TLR8 is a potential target for the development of new therapeutic agents aimed at modulating the immune response in autoimmune diseases and chronic infections.

Pharmacological Modulation

Recent research has focused on developing small molecule agonists and antagonists of TLR8 as potential therapeutic agents. TLR8 agonists are being explored as vaccine adjuvants to enhance the immune response to vaccines. On the other hand, TLR8 antagonists are being investigated for their potential to suppress inappropriate immune responses in autoimmune diseases and chronic inflammatory conditions.

Conclusion

TLR8 is a critical component of the innate immune system, playing a key role in the recognition of ssRNA from viruses and the activation of immune responses. Its involvement in various diseases makes it an attractive target for therapeutic intervention. Ongoing research into the modulation of TLR8 activity holds promise for the development of novel treatments for infectious diseases, autoimmune disorders, and chronic inflammatory conditions.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian